Prokidney Corp (PROK)

Apr 25, 2025

Is ProKidney Corp (PROK) positioned for future growth? - Sete News

Apr 25, 2025

Apr 25, 2025

ProKidney Corp (NASDAQ:PROK)’s 12-Month Price Target Currently Stands At 6 - Marketing Sentinel

Apr 25, 2025

Apr 24, 2025

Major Investment Alert: Carso De-C Inmobiliaria Acquires ProKidney Shares! - TipRanks

Apr 24, 2025

Apr 24, 2025

ProKidney Corp [PROK] Records 50-Day SMA of $1.0283 - knoxdaily.com

Apr 24, 2025

Apr 24, 2025

The Psychology of ProKidney Corp Inc. (PROK) Price Performance: Understanding Market Sentiment - investchronicle.com

Apr 24, 2025

Apr 23, 2025

Analytical Overview: ProKidney Corp (PROK)’s Ratios Tell a Financial Story - DWinneX

Apr 23, 2025

Apr 22, 2025

The ProKidney Corp (PROK) had a good session last reading, didn’t it? - uspostnews.com

Apr 22, 2025

Apr 21, 2025

Major Investment Alert: ProKidney Stock Sees New Stakeholder! - TipRanks

Apr 21, 2025

Apr 18, 2025

Major Investment Alert: ProKidney Stock Acquisition! - TipRanks

Apr 18, 2025

Apr 16, 2025

Major Investment Alert: ProKidney Stock Sees Significant Purchase! - TipRanks

Apr 16, 2025

Apr 15, 2025

Greensboro’s Once Great Win Is Now A ProKidney Failure - The Rhino Times of Greensboro -

Apr 15, 2025

Apr 14, 2025

Major Investment Alert: ProKidney Stock Sees Big Buy-In! - TipRanks

Apr 14, 2025

Apr 14, 2025

Control empresarial de capitales purchases $628,847 in ProKidney shares - Investing.com

Apr 14, 2025

Apr 14, 2025

Control empresarial de capitales purchases $628,847 in ProKidney shares By Investing.com - Investing.com Canada

Apr 14, 2025

Apr 13, 2025

Sei Investments Co. Makes New $69,000 Investment in ProKidney Corp. (NASDAQ:PROK) - Defense World

Apr 13, 2025

Apr 12, 2025

Critical Review: Candel Therapeutics (NASDAQ:CADL) & ProKidney (NASDAQ:PROK) - Defense World

Apr 12, 2025

Apr 08, 2025

PROK stock touches 52-week low at $0.49 amid market challenges - Investing.com India

Apr 08, 2025

Apr 07, 2025

Institutional owners may take dramatic actions as ProKidney Corp.'s (NASDAQ:PROK) recent 32% drop adds to one-year losses - simplywall.st

Apr 07, 2025

Mar 29, 2025

Bank of New York Mellon Corp Has $388,000 Holdings in ProKidney Corp. (NASDAQ:PROK) - Defense World

Mar 29, 2025

Mar 27, 2025

Here's Why We're Watching ProKidney's (NASDAQ:PROK) Cash Burn Situation - Yahoo Finance

Mar 27, 2025

Mar 21, 2025

Down -38% in 4 Weeks, Here's Why You Should You Buy the Dip in PROKIDNEY CP (PROK) - Yahoo Finance

Mar 21, 2025

Mar 20, 2025

PROK stock touches 52-week low at $0.94 amid market challenges - Investing.com India

Mar 20, 2025

Mar 20, 2025

ProKidney Corp reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 20, 2025

Mar 18, 2025

ProKidney Hold Rating: Balancing Developmental Progress and Financial Stability Amid Uncertainty - TipRanks

Mar 18, 2025

Mar 18, 2025

ProKidney Corp (PROK) Reports $163.3 Million Net Loss for 2024, - GuruFocus.com

Mar 18, 2025

Mar 18, 2025

ProKidney reports larger loss in 2024 as production resumes - Winston-Salem Journal

Mar 18, 2025

Mar 17, 2025

PROKIDNEY CORP. SEC 10-K Report - TradingView

Mar 17, 2025

Mar 17, 2025

ProKidney CEO cites 'significant progress' after regenerative medicine company loses $163M in 2024 - The Business Journals

Mar 17, 2025

Mar 17, 2025

ProKidney reports FY24 EPS (62c), consensus (59c) - TipRanks

Mar 17, 2025

Mar 17, 2025

ProKidney Corp. Reports 2024 Financial Results and Milestones in Rilparencel Development for Chronic Kidney Disease - Nasdaq

Mar 17, 2025

Mar 17, 2025

ProKidney Reports Full Year 2024 Financial Results and Business Highlights - GlobeNewswire

Mar 17, 2025

Mar 17, 2025

FDA Fast-Tracks ProKidney's CKD Treatment: $358M War Chest Fuels Breakthrough Development - StockTitan

Mar 17, 2025

Mar 13, 2025

Top 3 Health Care Stocks You'll Regret Missing This Quarter - Benzinga

Mar 13, 2025

Mar 13, 2025

ProKidney (PROK) Expected to Announce Quarterly Earnings on Thursday - Defense World

Mar 13, 2025

Feb 28, 2025

ProKidney (NASDAQ:PROK) Stock Price Down 2.7%Here's What Happened - MarketBeat

Feb 28, 2025

Feb 27, 2025

ProKidney stock hits 52-week low at $1.34 amid market challenges - Investing.com Australia

Feb 27, 2025

Feb 26, 2025

ProKidney stock hits 52-week low at $1.34 amid market challenges By Investing.com - Investing.com South Africa

Feb 26, 2025

Feb 26, 2025

Head to Head Review: ProKidney (NASDAQ:PROK) and Adaptimmune Therapeutics (NASDAQ:ADAP) - Defense World

Feb 26, 2025

Feb 25, 2025

Owning 32% shares,institutional owners seem interested in ProKidney Corp. (NASDAQ:PROK), - Yahoo

Feb 25, 2025

Feb 13, 2025

ProKidney Corp (NASDAQ: PROK) Has Great Upside Potential - Stocks Register

Feb 13, 2025

Feb 06, 2025

ProKidney Corp [PROK] Chief Regulatory Officer makes an insider sale of 16,412 shares worth 41,030. - Knox Daily

Feb 06, 2025

Feb 03, 2025

JPMorgan Chase & Co. Purchases 18,472 Shares of ProKidney Corp. (NASDAQ:PROK) - Defense World

Feb 03, 2025

Feb 01, 2025

Kuehn Law Encourages Investors of ProKidney Corp. to Contact Law Firm - The Malaysian Reserve

Feb 01, 2025

Jan 31, 2025

2025 Will Be A Major Year For ProKidney’s Rilparencel In CKD Treatment (NASDAQ:PROK) - Seeking Alpha

Jan 31, 2025

Jan 27, 2025

US Penny Stocks: 3 Picks With Market Caps Under $300M - Simply Wall St

Jan 27, 2025

Jan 23, 2025

ProKidney secures out-of-market buyer, $20.5 million price tag for Greensboro site - The Business Journals

Jan 23, 2025

Jan 23, 2025

ProKidney's high-profile Greensboro plant initiative ends with planned $20 million sale of property - Winston-Salem Journal

Jan 23, 2025